{"id":"mk0991-caspofungin-acetate","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"8%","effect":"Vomiting"},{"rate":"6%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Caspofungin acetate works by targeting the enzyme glucan synthase, which is essential for the production of beta-1,3-D-glucan in fungal cell walls.","oneSentence":"Inhibits the synthesis of beta-1,3-D-glucan, a critical component of fungal cell walls.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:39:08.733Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Invasive aspergillosis"},{"name":"Candidemia"},{"name":"Esophageal candidiasis"}]},"trialDetails":[{"nctId":"NCT05421858","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2024-12-11","conditions":"Candidemia, Candidiasis, Invasive","enrollment":450},{"nctId":"NCT00748345","phase":"PHASE2, PHASE3","title":"Pharmacokinetics of Caspofungin in Burn Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-02","conditions":"Thermal Injury","enrollment":2},{"nctId":"NCT04961593","phase":"","title":"PK/PD of Caspofungin in Children Severe Infection","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2022-10-01","conditions":"Pharmacokinetics, Infection, Fungal","enrollment":60},{"nctId":"NCT04368559","phase":"PHASE3","title":"Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mundipharma Research Limited","startDate":"2020-05-11","conditions":"Candidemia, Mycoses, Fungal Infection","enrollment":602},{"nctId":"NCT05178862","phase":"PHASE3","title":"A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole","status":"TERMINATED","sponsor":"Scynexis, Inc.","startDate":"2022-08-03","conditions":"Candidiasis, Invasive, Candidemia","enrollment":68},{"nctId":"NCT02805049","phase":"PHASE4","title":"Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis (EPI Study)","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2017-01-28","conditions":"Septic Shock, Peritonitis","enrollment":24},{"nctId":"NCT00238355","phase":"PHASE2","title":"Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2003-08","conditions":"Infection, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":13},{"nctId":"NCT06907992","phase":"","title":"A Study Comparing Short-course Antifungal Therapy (SCAT) 7 Day vs Standard 14 Day Antifungal Therapy for Uncomplicated Candidemia","status":"NOT_YET_RECRUITING","sponsor":"Augusta University","startDate":"2025-05-01","conditions":"Candidemia","enrollment":150},{"nctId":"NCT06892951","phase":"PHASE1, PHASE2","title":"CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2025-06","conditions":"Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection, Pneumocystis Infections","enrollment":100},{"nctId":"NCT00413218","phase":"PHASE3","title":"Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2007-03-08","conditions":"Candidiasis, Invasive, Candidemia, Mycoses","enrollment":450},{"nctId":"NCT06691321","phase":"","title":"Caspofungin for Pneumocystis Pneumonia in PLWHIV.","status":"RECRUITING","sponsor":"Instituto Nacional de Enfermedades Respiratorias","startDate":"2023-08-01","conditions":"HIV-1-infection, Pneumocystis Pneumonia","enrollment":60},{"nctId":"NCT01058174","phase":"PHASE3","title":"Liver Transplant European Study Into the Prevention of Fungal Infection","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-12-15","conditions":"Liver Transplantation, Mycoses","enrollment":350},{"nctId":"NCT06194201","phase":"PHASE2","title":"A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis","status":"RECRUITING","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2024-04-27","conditions":"Patients With Candidemia and/or Invasive Candidiasis","enrollment":40},{"nctId":"NCT01686607","phase":"","title":"Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2012-10-01","conditions":"Systemic Fungal Infections","enrollment":40110},{"nctId":"NCT01503515","phase":"PHASE3","title":"Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2013-03-21","conditions":"Fungal Infection, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":292},{"nctId":"NCT03580733","phase":"PHASE3","title":"Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2019-01-01","conditions":"ICU Yeast Intra-abdominal Infection","enrollment":448},{"nctId":"NCT04045366","phase":"","title":"Impact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2012-09-21","conditions":"Critically Ill Patients","enrollment":60},{"nctId":"NCT00839540","phase":"PHASE4","title":"Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins","status":"COMPLETED","sponsor":"Gary E. Stein, Pharm.D.","startDate":"2008-12","conditions":"Candidemia","enrollment":21},{"nctId":"NCT06137690","phase":"","title":"Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients","status":"UNKNOWN","sponsor":"People's Hospital of Zhengzhou University","startDate":"2018-07-01","conditions":"Invasive Fungal Infection","enrollment":550},{"nctId":"NCT01288378","phase":"PHASE3","title":"Empirical Versus Preemptive Antifungal Therapy","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2012-03","conditions":"Fungal Infection, Leukemia, Myelodysplastic Syndromes","enrollment":556},{"nctId":"NCT03399032","phase":"","title":"Pharmacokinetics of Caspofungin","status":"COMPLETED","sponsor":"Medical University of Lublin","startDate":"2018-02-05","conditions":"Septic Shock, Fungal Infection, Critical Illness","enrollment":33},{"nctId":"NCT06044558","phase":"","title":"Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics","status":"COMPLETED","sponsor":"LI YAN","startDate":"2022-09-01","conditions":"Kidney Transplant Patients","enrollment":507},{"nctId":"NCT05881109","phase":"","title":"Population Pharmacokinetics and Dose Optimization of Caspofungin in Adolescents","status":"COMPLETED","sponsor":"Shandong University","startDate":"2018-01-01","conditions":"Invasive Fungal Infections","enrollment":30},{"nctId":"NCT03667690","phase":"PHASE3","title":"Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis","status":"COMPLETED","sponsor":"Cidara Therapeutics Inc.","startDate":"2018-10-07","conditions":"Candidemia, Mycoses, Fungal Infection","enrollment":199},{"nctId":"NCT04728971","phase":"PHASE4","title":"To Evaluate the Efficacy and Safety of Micafungin in Preventing Invasive Mycosis After Liver Transplantation","status":"UNKNOWN","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2022-10-01","conditions":"Liver Transplantation","enrollment":200},{"nctId":"NCT04004078","phase":"","title":"An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM","status":"COMPLETED","sponsor":"People's Hospital of Zhengzhou University","startDate":"2018-03-01","conditions":"Invasive Fungal Infection","enrollment":314},{"nctId":"NCT01869829","phase":"","title":"PEACE: Pediatric Antifungal Comparative Effectiveness","status":"COMPLETED","sponsor":"Duke University","startDate":"2015-01","conditions":"Pediatric Invasive Candidiasis","enrollment":750},{"nctId":"NCT03857399","phase":"PHASE2","title":"Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin","status":"COMPLETED","sponsor":"Cttq","startDate":"2018-09-17","conditions":"Fungal Infection","enrollment":32},{"nctId":"NCT01307579","phase":"PHASE3","title":"Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2011-04-04","conditions":"Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia","enrollment":517},{"nctId":"NCT04674657","phase":"","title":"Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients","status":"UNKNOWN","sponsor":"Royal Brompton & Harefield NHS Foundation Trust","startDate":"2018-09-03","conditions":"Critical Illness, Extracorporeal Membrane Oxygenation Complication, Infection","enrollment":30},{"nctId":"NCT02734862","phase":"PHASE2","title":"CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension","status":"COMPLETED","sponsor":"Cidara Therapeutics Inc.","startDate":"2016-07-26","conditions":"Candidemia, Mycoses, Fungal Infection","enrollment":207},{"nctId":"NCT01533558","phase":"","title":"Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2012-01","conditions":"Invasive Fungal Infection","enrollment":20},{"nctId":"NCT04502771","phase":"","title":"Therapeutic Drug Monitoring of Antifungals in Intensive Care Units","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2018-01-01","conditions":"Intensive Care Unit Patients","enrollment":200},{"nctId":"NCT02603575","phase":"NA","title":"Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV Patients","status":"UNKNOWN","sponsor":"Beijing Chao Yang Hospital","startDate":"2015-11","conditions":"Pneumocystis Pneumonia","enrollment":60},{"nctId":"NCT03787550","phase":"","title":"PK/PD of the Sedatives, Analgesics and Antibiotics in Patients Receiving ECMO","status":"UNKNOWN","sponsor":"Guangdong Provincial People's Hospital","startDate":"2020-02-07","conditions":"Drug Effect","enrollment":36},{"nctId":"NCT01945281","phase":"PHASE2","title":"Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2014-01-15","conditions":"Candidiasis, Invasive","enrollment":51},{"nctId":"NCT03978559","phase":"PHASE4","title":"Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP","status":"UNKNOWN","sponsor":"Bin Du","startDate":"2019-08-14","conditions":"Pneumocystis Pneumonia","enrollment":122},{"nctId":"NCT02596984","phase":"NA","title":"Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2015-03-16","conditions":"Shock","enrollment":50},{"nctId":"NCT02895529","phase":"PHASE4","title":"A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy","status":"TERMINATED","sponsor":"Xian-Janssen Pharmaceutical Ltd.","startDate":"2016-11-30","conditions":"Hematologic Neoplasms","enrollment":61},{"nctId":"NCT01968395","phase":"PHASE4","title":"Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure","status":"COMPLETED","sponsor":"Erasme University Hospital","startDate":"2013-09","conditions":"Bacterial Infections and Mycoses, Liver Disease","enrollment":20},{"nctId":"NCT03798600","phase":"","title":"Pharmacokinetics/Pharmacodynamics (PK/PD) of Caspofungin in Intensive Care Unit (ICU) Patients. An Open Observational Study for Antifungal Treatment's Optimization","status":"COMPLETED","sponsor":"Careggi Hospital","startDate":"2016-01-01","conditions":"Critical Illness, Infection","enrollment":20},{"nctId":"NCT03652194","phase":"","title":"Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2018-01-01","conditions":"Candidemia of C. Glabrata","enrollment":21},{"nctId":"NCT01165320","phase":"PHASE2","title":"A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-07-06","conditions":"Candidiasis, Esophageal, Candidiasis, Invasive, Aspergillosis","enrollment":20},{"nctId":"NCT02856178","phase":"PHASE1, PHASE2","title":"Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients","status":"WITHDRAWN","sponsor":"F2G Biotech GmbH","startDate":"2017-04-20","conditions":"Pulmonary Aspergillosis - Invasive, Acute Myeloid Leukemia","enrollment":""},{"nctId":"NCT02413892","phase":"","title":"Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients","status":"COMPLETED","sponsor":"Outcome Rea","startDate":"2015-05","conditions":"Candida Infections","enrollment":15},{"nctId":"NCT00250432","phase":"PHASE3","title":"A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-01","conditions":"Invasive Candidiasis","enrollment":204},{"nctId":"NCT00635648","phase":"PHASE3","title":"A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-01","conditions":"Fungal Infection","enrollment":63},{"nctId":"NCT01045798","phase":"PHASE2","title":"Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-12","conditions":"Invasive Candidiasis","enrollment":15},{"nctId":"NCT00717860","phase":"PHASE3","title":"A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-08","conditions":"Fungal Infection","enrollment":121},{"nctId":"NCT00379964","phase":"PHASE3","title":"A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-06","conditions":"Fungal Infection","enrollment":50},{"nctId":"NCT00330395","phase":"PHASE2","title":"Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-05","conditions":"Candidiasis","enrollment":16},{"nctId":"NCT00083343","phase":"PHASE2","title":"Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-05","conditions":"Candidiasis","enrollment":48},{"nctId":"NCT00082537","phase":"PHASE2","title":"MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-04","conditions":"Neutropenia, Fever","enrollment":100},{"nctId":"NCT00292071","phase":"PHASE2","title":"Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-05","conditions":"Fungal Infection","enrollment":16},{"nctId":"NCT00082524","phase":"PHASE2","title":"Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-04","conditions":"Aspergillosis, Candidiasis","enrollment":50},{"nctId":"NCT01062165","phase":"PHASE4","title":"Effect of Weight and/or Obesity on Caspofungin Drug Concentrations","status":"COMPLETED","sponsor":"Texas Tech University Health Sciences Center","startDate":"2010-02","conditions":"Obesity, Fungal Infection","enrollment":18},{"nctId":"NCT02941068","phase":"PHASE2","title":"the Influence of Prophylactic and Empirical Anti-fungal Treatment in Severe Sepsis Patients With Perforations","status":"COMPLETED","sponsor":"Nanjing PLA General Hospital","startDate":"2012-03","conditions":"Intra-abdominal Perforation","enrollment":223},{"nctId":"NCT01501708","phase":"PHASE2","title":"Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2011-12","conditions":"Leukemia, Transplantation, Hematopoietic Stem Cell","enrollment":55},{"nctId":"NCT01213823","phase":"","title":"Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins","status":"TERMINATED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Invasive Candidiasis, Candidemia","enrollment":536},{"nctId":"NCT00548080","phase":"PHASE3","title":"Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-03","conditions":"Fungal Infection","enrollment":131},{"nctId":"NCT01994096","phase":"PHASE4","title":"Optimal Dosage of Caspofungin in Critically Ill Patients","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2013-11","conditions":"Critically Ill, Suspected Invasive Candidiasis","enrollment":20},{"nctId":"NCT02510053","phase":"NA","title":"Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2014-07","conditions":"Invasive Fungal Infection","enrollment":40},{"nctId":"NCT00334412","phase":"PHASE4","title":"COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2004-03","conditions":"Invasive Aspergillosis","enrollment":30},{"nctId":"NCT00076869","phase":"PHASE2","title":"MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2003-01","conditions":"Aspergillosis","enrollment":55},{"nctId":"NCT00095316","phase":"PHASE3","title":"Caspofungin Study for Fungal Infections in Adults in Critical Care Settings","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-10","conditions":"Candidiasis","enrollment":1200},{"nctId":"NCT00105144","phase":"PHASE3","title":"Study of Micafungin in Patients With Invasive Candidiasis or Candidemia","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2004-09","conditions":"Candidiasis, Candidemia","enrollment":611},{"nctId":"NCT00665639","phase":"PHASE3","title":"Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2004-06","conditions":"Candidiasis, Oral","enrollment":454},{"nctId":"NCT00982540","phase":"NA","title":"Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients","status":"TERMINATED","sponsor":"Universidade Federal do Rio de Janeiro","startDate":"2010-02","conditions":"Invasive Fungal Infections, Invasive Aspergillosis, Invasive Fusariosis","enrollment":28},{"nctId":"NCT01499433","phase":"PHASE4","title":"Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Guangzhou Medical University","startDate":"2012-01","conditions":"Invasive Pulmonary Aspergillosis, Chronic Obstructive Pulmonary Disease","enrollment":40},{"nctId":"NCT01318148","phase":"PHASE2","title":"Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis","status":"COMPLETED","sponsor":"Werner J. Heinz","startDate":"2011-04","conditions":"Fungal Infection","enrollment":25},{"nctId":"NCT00805740","phase":"PHASE3","title":"An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida","status":"TERMINATED","sponsor":"Pfizer","startDate":"2009-04","conditions":"Candidiasis, Fungemia","enrollment":41},{"nctId":"NCT00404092","phase":"PHASE2","title":"Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2006-10","conditions":"Invasive Aspergillosis","enrollment":46},{"nctId":"NCT00020527","phase":"NA","title":"Caspofungin Acetate in Treating Children With Fever and Neutropenia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-03","conditions":"Fever, Sweats, and Hot Flashes, Infection, Kidney Cancer","enrollment":""},{"nctId":"NCT00008359","phase":"PHASE3","title":"Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2000-08","conditions":"Cancer","enrollment":""},{"nctId":"NCT00806351","phase":"PHASE3","title":"An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System","status":"TERMINATED","sponsor":"Pfizer","startDate":"2009-08","conditions":"Fungemia, Neutropenia, Candidiasis","enrollment":21},{"nctId":"NCT00491426","phase":"","title":"Antimicrobial PK in Infants With Suspected or Confirmed Infection","status":"COMPLETED","sponsor":"Duke University","startDate":"2006-01","conditions":"Infection","enrollment":450},{"nctId":"NCT00110045","phase":"PHASE2","title":"Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant","status":"COMPLETED","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2005-02","conditions":"Cancer","enrollment":171},{"nctId":"NCT01260974","phase":"PHASE2","title":"Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients","status":"UNKNOWN","sponsor":"Azienda Ospedaliera di Padova","startDate":"2009-05","conditions":"Fungemia, Mycoses","enrollment":38},{"nctId":"NCT00520234","phase":"PHASE4","title":"Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)","status":"COMPLETED","sponsor":"Mycoses Study Group","startDate":"2007-08","conditions":"Invasive Candidiasis","enrollment":222},{"nctId":"NCT00723073","phase":"","title":"Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2008-01","conditions":"Febrile Neutropenia","enrollment":323},{"nctId":"NCT01040156","phase":"","title":"Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation","status":"COMPLETED","sponsor":"University Children's Hospital Tuebingen","startDate":"2008-08","conditions":"Systemic Aspergillosis, Systemic Candidiasis","enrollment":""},{"nctId":"NCT00501098","phase":"PHASE2","title":"Prophylaxis of Fungal Invasive Infections in Leukemia","status":"COMPLETED","sponsor":"Northern Italy Leukemia Group","startDate":"2007-01","conditions":"Invasive Pulmonary Aspergillosis","enrollment":100},{"nctId":"NCT00388167","phase":"","title":"Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection","status":"COMPLETED","sponsor":"PETHEMA Foundation","startDate":"2004-03","conditions":"Candidiasis, Aspergillosis","enrollment":320},{"nctId":"NCT00099775","phase":"PHASE3","title":"Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-12","conditions":"Candidiasis","enrollment":1200},{"nctId":"NCT00148148","phase":"PHASE2","title":"A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2004-05","conditions":"Hematopoietic Stem Cell Transplantation, Fungus Diseases","enrollment":75},{"nctId":"NCT00333645","phase":"PHASE2","title":"Prophylaxis With Caspofungin in High-Risk Liver Transplantation","status":"UNKNOWN","sponsor":"Grupo de Estudio de Infecciones en Transplantados","startDate":"2003-10","conditions":"Liver Transplantation, Fungal Infection","enrollment":70},{"nctId":"NCT00005920","phase":"PHASE2","title":"Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"Candidiasis, Oral, HIV Infections","enrollment":70},{"nctId":"NCT00005921","phase":"NA","title":"A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"Candidiasis, Esophageal, HIV Infections","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":95,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"MK0991, caspofungin acetate","genericName":"MK0991, caspofungin acetate","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Caspofungin acetate, also known as MK0991, is an antifungal medication used to treat various fungal infections, including Pneumocystis pneumonia, systemic aspergillosis, and unspecified adult solid tumor fungal infections. It has been studied in combination with corticosteroids for the treatment of Pneumocystis pneumonia in non-HIV patients.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}